Lake Street analyst Ben Klieve reiterates a Buy rating and $30 price target on Bioceres, which he also named as his small cap agribusiness pick of 2023 given his view that the company enters the year with "significant operational tailwinds and emerging commercial catalysts." He believes favorable demand trends, the HB4 commercial ramp, Pro Farm integration, and a Syngenta agreement ramp "can accelerate financial performance in the new year" for Bioceres, Klieve said.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BIOX: